Navigation Links
USC study finds sex, age and ethnicity assciated with colorectal cancer survival
Date:5/29/2008

Chicago, Ill.--The interaction of sex, age and ethnicity has a significant impact on overall survival in metastatic colorectal cancer (MCRC) patients, a study led by researchers at the University of Southern California (USC) and USC/Norris Comprehensive Cancer Center suggests.

While age and ethnicity are well-established factors that impact survival in colorectal cancer, the study found that gender also plays an important role in overall survival, says Andrew Hendifar, M.D., MPH, fellow in the division of hematology/oncology at the Keck School of Medicine of USC and lead author of the study. Researchers found that pre-menopausal women with metastatic colorectal cancer (18-44 years old) lived longer than younger men, while older women (75 and older) had significantly worse overall survival than older men.

The results of the study will be presented at a poster discussion Sunday, June 1, at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO) held at McCormick Place in Chicago.

The study adds to the growing evidence that female hormones are protective for colon cancer, researchers say.

"This study provides further evidence that estrogen may play an important role not only in colon cancer development but also progression of the disease, and may impact how we develop therapies for women and men with colon cancer," says Heinz-Josef Lenz, M.D., professor of medicine at the Keck School of Medicine and a senior investigator on the study.

Researchers screened 56,598 patients with metastatic colorectal cancer from 1988 to 2003, using the Surveillance, Epidemiology and End Results (SEER) registry. Models were created using the patients' age at diagnosis, sex, ethnicity and overall survival. Independent of age, there were no survival differences between men and women with MCRC. However, when age was added to the model, sex became significantly associated with survival across all ethnicities.

<
'/>"/>
Contact: Meghan Lewit
lewit@usc.edu
323-442-3576
University of Southern California
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Montana Center for Work Physiology and Exercise Metabolism presents firefighter health study
2. Moonview Sanctuary Releases First Case Study of Client Treated Using Unique Moonview Model
3. Montana Center for Work Physiology and Exercise Metabolism Presents Firefighter Health Study
4. Establishing a Price for Carbon Emissions in the U.S. Would Spur Immediate Reductions in Energy Consumption and More Efficient Use of Power Generators, Study by Carnegie Mellon Researchers Shows
5. Study IDs Gene for Late-Onset Alzheimers
6. Study: Child maltreatment victims lose 2 years of quality of life
7. New study shows sedentary high school girls are at significant risk for future osteoporosis
8. $1.3M NIH grant to fund Parkinsons disease study
9. New vaccine approach prevents/reverses diabetes in lab study at Childrens Hospital of Pittsburgh
10. New Study of Bush Medicare Cuts: Texas Rural Seniors, Nursing Homes 2nd Hardest Hit in Nation
11. Research Study Shows That Pharmaceutical Field Sales Reps Productivity Inhibited by Unnecessary Internal Communication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... on prevention, experts say , , THURSDAY, Dec. 17 ... getting better at treating heart attacks and other ... basic rules for preventing them, according to new ... the list: too little exercise, too much weight. ... last year reported no activity vigorous enough to ...
(Date:12/17/2009)... the outbreak is a good time to get vaccinated, ... News) -- As the current wave of H1N1 swine ... urged that everyone get vaccinated in case another outbreak ... the H1N1 flu vaccine have eased, it,s an ideal ... Services Secretary Kathleen Sebelius said during a morning press ...
(Date:12/17/2009)... Reportlinker.com announces that a new ... catalogue: ,, India Healthcare IT Investment ... ,, http://www.reportlinker.com/p0169911/India-Healthcare-IT-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html ,, India Healthcare ... 2015 ,, Summary ,, This ... information and data relating to India healthcare ...
(Date:12/17/2009)... Dec. 17 Today, CDC,s Morbidity and ... that the number of state-level epidemiologists has decreased ... over 10% since 2006. There was also a ... same period, including epidemiology capacity for bioterrorism and ... areas such as occupational health, substance abuse, and ...
(Date:12/17/2009)... Dec. 17 /PRNewswire-Asia/ -- China,s leading high-tech,healthcare group, ... Stock Code: 801) is pleased to announce today ... period under review, the Group,s two,associate companies made ... and NASDAQ;,its key businesses have been strengthened, with ... management operations. , Mr. ...
Breaking Medicine News(10 mins):Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3Health News:Swine Flu Wanes, But Future Uncertain 2Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 2Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 3Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 4Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 5Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 6Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 7Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 8Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3
... Chemical peels using either alpha-hydroxy acid or beta-hydroxy acid are ... acne, researchers at the Saint Louis University School of Medicine ... different types of acid peels as therapies for the skin ... fewer side effects and results that lasted a bit longer ...
... expanded major clinical trial involving the use of gene therapy ... treatment is more effective than radiation therapy alone for patients ... part of a $9 million grant from the National Cancer ... of gene therapy to treat prostate cancer. , ...
... to seek restatement of Beth Israel Deaconess,Medical Center audit, ... Douglas T. Linde should apply the same Sarbanes-Oxley,standards used ... role on the board of Beth Israel Deaconess Medical ... Workers East. Linde is,also the president and CFO of ...
... transplant is a life saving treatment option for people ... livers far exceeds the supply. Each year only about ... receive one, and some patients die while waiting. In ... how the current system for allocating donor organs in ...
... 6 Sodium and salt levels in foods and,beverages are ... U.S. food,and beverage industry. Why? In two words -- health ... Reduced or No Sodium or Salt,Foods and Beverages in the ... products, foodservice menu items and beverages. All of,which have been ...
... , Scientists from the University of Bonn are researching ... million years ago. They want to find out how the dinosaurs ... fact such gigantic animals should not have existed. The results of ... the Royal Society B,. , Take 200 milligrammes of dried and ...
Other Medicine News:Health News:Treating acne: 2 different acid peels are both effective, study finds 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 3Health News:Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 3Health News:Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns 2Health News:Bonn scientists simulate dinosaur digestion in the lab 2Health News:Bonn scientists simulate dinosaur digestion in the lab 3
(Date:12/17/2009)... (Nasdaq: ANDS ) today announced preliminary results from a ... first dose cohort, 200 mg bid, in an ongoing Phase ... ribavirin (SOC) in HCV patients. 56% of patients receiving ... at week 4, known as R apid V ... patients receiving placebo plus SOC. ,, ANA598 was ...
(Date:12/17/2009)... -- Decision Resources, one of the world,s leading ... healthcare issues, finds that over 70 percent of ... need for diabetes drugs with novel mechanisms of ... a high need for additional DPP-IV inhibitors. Both ... glucose lowering ability and physicians in particular say ...
(Date:12/17/2009)... Dec. 17 Protalix BioTherapeutics, Inc. (NYSE-Amex: ... Sandra Lauterbach to Vice President, Sales and Commercial ... position, Ms. Lauterbach will be responsible for all ... taliglucerase alfa in accordance with the collaboration agreement ... as any other products that emerge from the ...
Breaking Medicine Technology:ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 2ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 3ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 4ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 5ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 6ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 7Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 2Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4Dr Julian Whitaker Featured on Searchhearthealth com 51293 1Dr Julian Whitaker Featured on Searchhearthealth com 51293 2Shoulder Surgery Doesnt Prevent Return to Sports 4709 1Shoulder Surgery Doesnt Prevent Return to Sports 4709 2Material world 3A Graphenes versatility promises new applications 12967 1Material world 3A Graphenes versatility promises new applications 12967 2Material world 3A Graphenes versatility promises new applications 12967 3Material world 3A Graphenes versatility promises new applications 12967 4
... from an Otsuka Pharmaceutical Co, Ltd. Sponsored ... Meeting -, SAN DIEGO, May 23, 2007 ... (13- 17 years old) with schizophrenia, the ... atypical,antipsychotic aripiprazole demonstrated significant improvement,compared to placebo ...
... SAN DIEGO, California, 23 May 2007 - The ... symptoms in,depressed patients who did not respond, or ... reuptake,inhibitor (SSRI), regardless of whether those patients were,switched ... This new,data was presented today at the American ...
Other Medicine Technology:Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 2In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 3In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 4In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 5In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 6In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 7In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 8In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 9
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: